As of 09-Oct-2026
2QCY26 · PKR amounts, EPS/DPS per share · YoY
Keep the current chart as the default, or switch to TradingView for advanced tools.
Prices adjusted for bonuses & splits
Revenue
Rs 5.9B
6MCY26: Rs 12.7B (+5.5%)
Net profit
Rs 722M
6MCY26: Rs 1.7B (+3.1%)
EPS
Rs 13.62
6MCY26: Rs 31.66 (+3.1%)
DPS
Rs 0.00
6MCY26: Rs 0.00
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
Choose a section to view its metrics and trend.
Closely held shares
31.79M (60.00%)
Free Float shares
21.19M (40.00%)
Market Cap
49.23B
#4 of 14 in Pharmaceuticals Companies
More announcements are available in the full announcements tab.
Fundamental metrics to determine fair value of the stock
P/E History
Companies ranked closest to HINOON by market capitalisation among the 14 companies in the Pharmaceuticals sector.
| SymbolCompany | Price (PKR) | Market cap | P/E | Dividend yield |
|---|---|---|---|---|
| GLAXO GlaxoSmithKline Pakistan | 316.6 | Rs 99.6B | 9.6x | 6.1% |
| ABOT Abbott Laboratories (Pakistan | 926.5 | Rs 90.5B | 10.5x | 4.3% |
| HALEON Haleon Pakistan | 685.4 | Rs 78.9B | 12.1x | 4.5% |
| HINOON Highnoon Laboratories (this stock) | 929.1 | Rs 49.2B | 11.8x | 5.4% |
| SEARL The Searle Company | 77.86 | Rs 45.6B | 104.4x | - |
| AGP AGP | 155.48 | Rs 43.8B | 11.9x | 5.1% |
| HPL Hoechst Pakistan | 3,961.82 | Rs 38.1B | 10.1x | 6.8% |
Highnoon Laboratories Limited (“the Company”) was incorporated in Pakistan under the repealed Companies Ordinance 1984 (now Companies Act, 2017) (“the Act”) and its shares are quoted on Pakistan Stock Exchange since November 1994. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and related consumer products. Highnoon Laboratories Limited (HINOON) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is a constituent of the KSE-100 index. It is marked Shariah-compliant on the KMI screening.
Highnoon Laboratories Limited (“the Company”) was incorporated in Pakistan under the repealed Companies Ordinance 1984 (now Companies Act, 2017) (“the Act”) and its shares are quoted on Pakistan Stock Exchange since November 1994. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and related consumer products.
Highnoon Laboratories Limited (HINOON) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is a constituent of the KSE-100 index. It is marked Shariah-compliant on the KMI screening.
Market data on FinHisaab is delayed and dates are shown where a figure is time-sensitive. This page is for information only and is not investment advice.
Use FinHisaab's screener and focused landing pages to compare HINOON with dividend stocks, undervalued ideas, and KSE-100 companies across the Pakistan Stock Exchange.
